Defining the pathway of biomarkers for pharmacodynamics, efficacy and toxicity for 11B-HSD1 inhibition in metabolic disease indications

Project Details

StatusFinished
Effective start/end date1/04/0730/06/12

Funding

  • UK industry, commerce and public corporations: £1,112,195.00